Mid-Day Breakouts Report - Monday, July 18th, 2022

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, October 20, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - MONDAY, JULY 18TH, 2022
Previous Mid Day Report Next Mid Day Report >>>

DOW 31487.87 199.61 (0.64%) | NASDAQ 11610.62 158.2 (1.38%) | S&P 500 3894.43 31.27 (0.81%)

Time of Screening : 7/18/2022 12:11:16 PM Report Released : 7/18/2022 12:49:42 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 45% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Pivot Point
Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Max Buy
HRMY - NASDAQ Harmony Biosciences Holdings	$54.60	+0.95 1.77%	$55.78	525,933 109.34% of 50 DAV 50 DAV is 481,000	$57.13 -4.43%	7/6/2022	$54.12	PP = $52.85 MB = $55.49
Most Recent Note - 7/18/2022 12:34:39 PM Y - Posting a gain today, trading near its 52-week high. Held its ground after recently triggering a technical buy signal. Prior highs in the $52-54 area define initial support to watch on pullbacks. Reported strong sales revenues and earnings increases in quarterly comparisons through Mar '22 versus the year ago periods. Annual earnings history is limited. Completed its $24 IPO on 8/19/20. >>> The latest Featured Stock Update with an annotated graph appeared on 7/6/2022. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
IMXI - NASDAQ International Money Express	$22.22	+0.82 3.83%	$22.62	200,149 48.82% of 50 DAV 50 DAV is 410,000	$22.94 -3.14%	7/1/2022	$21.27	PP = $21.38 MB = $22.45
Most Recent Note - 7/18/2022 12:36:22 PM Y - Posting a 2nd consecutive volume-driven gain today trading near its 52-week high. Held its ground after it recently broke out of a "double bottom" base. Its 50 DMA line ($20.34) defines important near-term support to watch. Fundamentals through the Mar '22 quarter have been strong. >>> The latest Featured Stock Update with an annotated graph appeared on 7/15/2022. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
ALKS - NASDAQ - Medical-Biomed/Biotech Alkermes Plc	$30.31	+0.38 1.27%	$30.81	$33.00	-8.15%	973,327 64.98%	1,498,000
Most Recent Note for ALKS - 7/18/2022 12:12:47 PM Recently challenged its 52-week high and it is consolidating above its 50 DMA line ($29.10). Prior mid-day report noted - "Reported earnings +9% on +11% sales revenues for the Mar '22 quarter versus the year ago period. Fundamental concerns remain. Earnings history is not a match with the fact-based investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ASH - NYSE - ENERGY - Oil & Gas Refining & Marketing Ashland Inc	$101.91	+3.16 3.20%	$103.47	$112.91	-9.74%	403,822 100.20%	403,000
Most Recent Note for ASH - 7/18/2022 12:15:38 PM Rebounding above its 200 DMA line with today's gain challenging its 50 DMA line ($101.60) and recent highs, now perched -9.8% off its all-time high. Prior mid-day reports cautioned members - "Reported earnings +79% on +19% sales revenues for the Mar '22 quarter versus the year ago period. Annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
AZN - NYSE - DRUGS - Drug Manufacturers - Major Astrazeneca Plc Ads	$67.31	-0.05 -0.07%	$68.17	$71.70	-6.12%	4,212,647 61.08%	6,897,000
Most Recent Note for AZN - 7/18/2022 12:16:28 PM Found support near its 50 DMA line with a volume-driven gain on the prior session. Little resistance remains due to overhead supply up to the $71 level. Prior mid-day reports noted - "Prior quarterly and annual earnings history is not a match with the fundamental guidelines of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CCRN - NASDAQ - DIVERSIFIED SERVICES - Staffing & Outsourcing Service Cross Country Healthcare	$28.15	+2.01 7.69%	$28.18	$30.40	-7.40%	493,803 104.84%	471,000
Most Recent Note for CCRN - 7/18/2022 12:18:41 PM It has not formed a sound base but is rallying toward its 52-week high with today's 3rd consecutive volume-driven gain adding to a recent spurt. Faces little resistance up to the $30 area. Recent quarterly comparisons through Mar '22 versus the year ago period showed strong sales revenues and earnings increases. Annual earnings growth (A criteria) has been strong since a downturn in FY '17 and '18.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ECPG - NASDAQ - FINANCIAL SERVICES - Credit Services Encore Capital Group Inc	$64.77	-0.21 -0.32%	$66.65	$72.67	-10.87%	173,476 55.25%	314,000
Most Recent Note for ECPG - 7/18/2022 12:25:30 PM Today's gain is adding to recent volume-driven gains. Prior mid-day reports cautioned members - "Reported the Mar '22 quarter with strong +115% earnings on +20% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria)."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ELA - AMEX - Retail/Whlsle-Jewelry Envela Corporation	$7.54	+0.18 2.45%	$7.64	$7.74	-2.58%	51,762 64.70%	80,000
Most Recent Note for ELA - 7/18/2022 12:31:24 PM Hovering near its all time high holding its ground after volume-driven gains. Prior mid-day reports noted - "Reported strong Mar '22 quarterly results versus the year ago period. Prior sales revenues and earnings history has not been a great match with the fact-based investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
EVOP - NASDAQ - Finance-CrdtCard/PmtPr Evo Payments Inc	$25.46	-0.49 -1.89%	$26.50	$29.95	-14.99%	141,741 48.21%	294,000
Most Recent Note for EVOP - 7/18/2022 12:31:47 PM Challenging prior highs with today's gain adding to recent volume-driven gains, but it faces resistance due to overhead supply up to the $31 level. Reported strong earnings increases in the 4 latest quarterly comparisons through Mar '22 versus the year ago periods. Annual earnings (A criteria) had a downturn in FY '20. Completed its $16 IPO on 5/23/18 and additional Public Offerings on 9/20/18 and 4/03/19.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
FNKO - NASDAQ - Leisure-Toys/Games/Hobby Funko Inc Cl A	$23.07	-0.40 -1.70%	$23.42	$25.93	-11.03%	561,309 65.34%	859,000
Most Recent Note for FNKO - 7/18/2022 12:33:00 PM Consolidating quietly after challenging its May 2021 high with recent volume-driven gains. Quarterly comparisons through Mar '22 showed strong earnings increases (C criteria) with great sales revenues growth. Annual earnings (A criteria) history remains a concern after a big downturn in FY '20.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MGPI - NASDAQ - FOOD & BEVERAGE - Processed & Packaged Goods M G P Ingredients Inc	$106.99	+2.12 2.02%	$108.26	$106.15	0.79%	83,129 55.79%	149,000
Most Recent Note for MGPI - 7/18/2022 12:38:03 PM Hitting new all-time highs with today's 2nd consecutive gain. Its 50 DMA line ($96.60) defines near-term support to watch on pullbacks. Reported earnings +66% on 80% sales revenues for the Mar '22 quarter versus the year ago period. Three of the past 4 quarterly comparisons were above the +25% minimum guideline (C criteria). Downturn in FY '18 annual earnings history (A criteria) has been followed by increases.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NVO - NYSE - DRUGS - Drug Manufacturers - Other Novo Nordisk A/S Adr	$115.32	+1.09 0.95%	$115.72	$122.16	-5.60%	869,008 60.98%	1,425,000
Most Recent Note for NVO - 7/18/2022 12:39:34 PM This Denmark-based Medical - Ethical Drug firm found support near its 200 DMA line and is rebounding near its all-time high. Prior mid-day reports repeatedly cautioned members - "Fundamental concerns remain after it reported Mar '22 quarterly earnings +8% on +17% sales revenues versus the year ago period."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PAG - NYSE - Retail/Whlsle-Automobile Penske Automotive Grp	$109.14	+3.64 3.45%	$110.52	$123.60	-11.70%	167,160 45.18%	370,000
Most Recent Note for PAG - 7/18/2022 12:42:44 PM A rebound above the 50 DMA line ($110.91) is needed for its outlook to improve. Found support near its 200 DMA line ($104.47) after dropped from the Featured Stocks list on 6/30/22.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SAFM - NASDAQ - FOOD & BEVERAGE - Meat Products Sanderson Farms Inc	$209.70	-3.02 -1.42%	$213.83	$221.63	-5.38%	310,709 95.31%	326,000
Most Recent Note for SAFM - 7/18/2022 12:44:50 PM Pulling back from near its all-time high testing its 50 DMA line($202.79) with today's volume-driven loss. Prior mid-day reports noted - "Reported very strong sales revenues and earnings increases in quarterly comparisons through Apr '22 versus the year ago periods. Sub par annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines. Consolidating since M&A news 8/09/21 with Cargill."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
VRRM - NASDAQ - Computer Sftwr-Spec Enterprs Verra Mobility Corp	$16.64	+0.55 3.42%	$16.88	$18.13	-8.22%	1,046,367 105.80%	989,000
Most Recent Note for VRRM - 7/18/2022 12:47:44 PM Today's 3rd consecutive volume-driven gain has it challenging prior highs. Little resistance remains up to the $18 level. Quarterly earnings in the past 4 comparisons through Mar '22 showed earnings increases above the +25% minimum guideline (C criteria) with strong sales revenues growth. Annual earnings (A criteria) history has been up and down.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.